By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion today said that it has priced a public offering of 4 million shares of common stock at $5.45 per share.

The offering is expected to bring in gross proceeds of $21.8 million and net proceeds of around $20.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.